S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
Sponsored by SWOG Cancer Research Network
About this study
This trial has two cohorts of patients with human epidermal growth factor receptor (HER)-2-positive breast cancer that has spread to other places in the body. All patients must be receiving trastuzumab-based treatment. Both cohorts are being observed for cardiac toxicity. The largest cohort (currently open to accrual) is observational, and contains patients who are taking a beta blocker, ACE inhibitor, or ARB as well as their trastuzumab-based treatment. The goal is to understand how common cardiac problems are in this group of patients at high risk. The smaller cohort (currently closed to accrual) is randomized. Patients in this second cohort are randomized to either carvedilol or no treatment, with the goal of seeing whether carvedilol (used to treat heart failure and high blood pressure) may prevent the heart from side effects of chemotherapy.
PRIMARY OBJECTIVES: I. To estimate the 2-year cumulative incidence of cardiac dysfunction and/or predefined cardiac events in patients with metastatic breast cancer receiving trastuzumab-based HER-2 targeted therapy and beta blockers, angiotensin receptor blocker (ARB), or angiotensin converting enzyme (ACE) inhibitor. II. To develop a model including clinical factors and potential biomarkers to predict risk of cardiac dysfunction and/or predefined cardiac events in patients with metastatic breast cancer receiving trastuzumab-based HER-2 targeted therapy and beta blockers, angiotensin receptor blocker (ARB), or angiotensin converting enzyme (ACE) inhibitor. SECONDARY OBJECTIVES: I. To assess whether prophylactic beta blocker therapy with carvedilol compared with no prophylaxis reduces …
Where this study is enrolling (144)
- I'm interested
City of Hope Comprehensive Cancer Center
Duarte, California
- Call 323-865-0451
USC / Norris Comprehensive Cancer Center
Los Angeles, California
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 925-957-5400
Contra Costa Regional Medical Center
Martinez, California
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- I'm interested
City of Hope Mission Hills
Mission Hills, California
- Call 877-467-3411
City of Hope Newport Beach
Newport Beach, California
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
Show all 144 locations
- I'm interested
City of Hope South Pasadena
South Pasadena, California
- Call 877-467-3411
City of Hope South Bay
Torrance, California
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- I'm interested
City of Hope Upland
Upland, California
- I'm interested
Beebe Health Campus
Rehoboth Beach, Delaware
- I'm interested
Bayhealth Hospital Kent Campus
Dover, Delaware
- I'm interested
Beebe South Coastal Health Campus
Frankford, Delaware
- I'm interested
Moffitt Cancer Center
Tampa, Florida
- I'm interested
Cleveland Clinic-Weston
Weston, Florida
- I'm interested
Lewis Hall Singletary Oncology Center
Thomasville, Georgia
- I'm interested
Emory University Hospital/Winship Cancer Institute
Atlanta, Georgia
- I'm interested
Northside Hospital
Atlanta, Georgia
- I'm interested
Northeast Georgia Medical Center-Gainesville
Gainesville, Georgia
- I'm interested
Lewis Cancer and Research Pavilion at Saint Joseph's/Candler
Savannah, Georgia
- I'm interested
Saint Alphonsus Cancer Care Center-Boise
Boise, Idaho
- I'm interested
Saint Alphonsus Cancer Care Center-Nampa
Nampa, Idaho
- I'm interested
Decatur Memorial Hospital
Decatur, Illinois
- Call 708-226-4357
Loyola University Medical Center
Maywood, Illinois
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- I'm interested
Cancer Care Center of O'Fallon
O'Fallon, Illinois
- Call (312) 864-0200
John H Stroger Jr Hospital of Cook County
Chicago, Illinois
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- I'm interested
Franciscan Saint Elizabeth Health - Lafayette East
Lafayette, Indiana
- Call 317-528-7060
Franciscan Health Indianapolis
Indianapolis, Indiana
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 317-834-3603
Franciscan Health Mooresville
Mooresville, Indiana
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- I'm interested
Mercy Medical Center-West Lakes
West Des Moines, Iowa
- Call 515-241-3305
Medical Oncology and Hematology Associates-West Des Moines
Clive, Iowa
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 515-241-3305
Mission Cancer and Blood - Laurel
Des Moines, Iowa
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- I'm interested
Mercy Medical Center - Des Moines
Des Moines, Iowa
- I'm interested
Mercy Cancer Center-West Lakes
Clive, Iowa
- I'm interested
University of Kansas Hospital-Indian Creek Campus
Overland Park, Kansas
- I'm interested
University of Kansas Cancer Center-Overland Park
Overland Park, Kansas
- I'm interested
University of Kansas Hospital-Westwood Cancer Center
Westwood, Kansas
- Call 785-623-5774
HaysMed University of Kansas Health System
Hays, Kansas
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- I'm interested
University of Kansas Cancer Center-West
Kansas City, Kansas
- I'm interested
University of Kansas Cancer Center
Kansas City, Kansas
- I'm interested
Olathe Health Cancer Center
Olathe, Kansas
- Call 785-295-8000
University of Kansas Health System Saint Francis Campus
Topeka, Kansas
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- I'm interested
Saint Joseph Hospital East
Lexington, Kentucky
- I'm interested
Mary Bird Perkins Cancer Center
Baton Rouge, Louisiana
- I'm interested
LSU Health Baton Rouge-North Clinic
Baton Rouge, Louisiana
- I'm interested
Woman's Hospital
Baton Rouge, Louisiana
- I'm interested
Our Lady of the Lake Medical Oncology
Baton Rouge, Louisiana
- I'm interested
Louisiana Hematology Oncology Associates
Baton Rouge, Louisiana
- I'm interested
Our Lady of the Lake Physicians Group - Medical Oncology
Baton Rouge, Louisiana
- I'm interested
Louisiana Hematology Oncology Associates LLC
Baton Rouge, Louisiana
- Call 443-643-3010
UM Upper Chesapeake Medical Center
Bel Air, Maryland
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- I'm interested
Winchester Hospital
Winchester, Massachusetts
- I'm interested
Lahey Hospital and Medical Center
Burlington, Massachusetts
- I'm interested
Spectrum Health at Butterworth Campus
Grand Rapids, Michigan
- I'm interested
Karmanos Cancer Institute at McLaren Greater Lansing
Lansing, Michigan
- I'm interested
Ascension Providence Hospitals - Southfield
Southfield, Michigan
- I'm interested
Saint Joseph Mercy Hospital
Ann Arbor, Michigan
- Call 800-865-1125
University of Michigan Comprehensive Cancer Center
Ann Arbor, Michigan
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- I'm interested
McLaren Cancer Institute-Bay City
Bay City, Michigan
- I'm interested
Henry Ford Cancer Institute-Downriver
Brownstown, Michigan
- I'm interested
McLaren Cancer Institute-Clarkston
Clarkston, Michigan
- I'm interested
Henry Ford Macomb Hospital-Clinton Township
Clinton Township, Michigan
- I'm interested
Henry Ford Medical Center-Fairlane
Dearborn, Michigan
- I'm interested
Wayne State University/Karmanos Cancer Institute
Detroit, Michigan
- I'm interested
Henry Ford Hospital
Detroit, Michigan
- I'm interested
McLaren Cancer Institute-Flint
Flint, Michigan
- I'm interested
Singh and Arora Hematology Oncology PC
Flint, Michigan
- I'm interested
McLaren Cancer Institute-Lapeer Region
Lapeer, Michigan
- I'm interested
McLaren Cancer Institute-Macomb
Mount Clemens, Michigan
- I'm interested
Henry Ford Medical Center-Columbus
Novi, Michigan
- I'm interested
Henry Ford West Bloomfield Hospital
West Bloomfield, Michigan
- I'm interested
Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus
Ypsilanti, Michigan
- I'm interested
Minnesota Oncology Hematology PA-Woodbury
Woodbury, Minnesota
- I'm interested
Hennepin County Medical Center
Minneapolis, Minnesota
- I'm interested
Regions Hospital
Saint Paul, Minnesota
- I'm interested
United Hospital
Saint Paul, Minnesota
- I'm interested
Park Nicollet Clinic - Saint Louis Park
Saint Louis Park, Minnesota
- I'm interested
Monticello Cancer Center
Monticello, Minnesota
- I'm interested
Mercy Hospital
Coon Rapids, Minnesota
- I'm interested
Minnesota Oncology Hematology PA-Maplewood
Maplewood, Minnesota
- I'm interested
Abbott-Northwestern Hospital
Minneapolis, Minnesota
- Call 601-815-6700
University of Mississippi Medical Center
Jackson, Mississippi
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- I'm interested
Baptist Memorial Hospital and Cancer Center-Golden Triangle
Columbus, Mississippi
- Call 417-269-4520
Mercy Hospital Springfield
Springfield, Missouri
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 816-404-4375
Truman Medical Centers
Kansas City, Missouri
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- I'm interested
University of Kansas Cancer Center - Lee's Summit
Lee's Summit, Missouri
- Call 314-251-7058
Saint Louis Cancer and Breast Institute-Ballwin
Ballwin, Missouri
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- I'm interested
Saint Francis Medical Center
Cape Girardeau, Missouri
- I'm interested
Capital Region Southwest Campus
Jefferson City, Missouri
- I'm interested
University of Kansas Cancer Center - North
Kansas City, Missouri
- I'm interested
University of Kansas Cancer Center at North Kansas City Hospital
North Kansas City, Missouri
- Call 417-269-4520
CoxHealth South Hospital
Springfield, Missouri
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 314-353-1870
Saint Louis Cancer and Breast Institute-South City
St Louis, Missouri
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- I'm interested
Mercy Hospital South
St Louis, Missouri
- Call 314-996-5569
Missouri Baptist Medical Center
St Louis, Missouri
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 314-251-7066
Mercy Hospital Saint Louis
St Louis, Missouri
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- I'm interested
Benefis Healthcare- Sletten Cancer Institute
Great Falls, Montana
- Call 908-522-2043
Overlook Hospital
Summit, New Jersey
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 973-971-5900
Morristown Medical Center
Morristown, New Jersey
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 201-833-6312
Holy Name Hospital
Teaneck, New Jersey
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- I'm interested
University of New Mexico Cancer Center
Albuquerque, New Mexico
- Call 845-348-8507
Nyack Hospital
Nyack, New York
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- I'm interested
Dickstein Cancer Treatment Center
White Plains, New York
- I'm interested
UHHS-Chagrin Highlands Medical Center
Beachwood, Ohio
- I'm interested
Aultman Health Foundation
Canton, Ohio
- I'm interested
Geauga Hospital
Chardon, Ohio
- Call 513-585-0844
The Christ Hospital
Cincinnati, Ohio
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- I'm interested
University of Cincinnati Cancer Center-UC Medical Center
Cincinnati, Ohio
- I'm interested
Case Western Reserve University
Cleveland, Ohio
- I'm interested
Cleveland Clinic Cancer Center/Fairview Hospital
Cleveland, Ohio
- I'm interested
Cleveland Clinic Foundation
Cleveland, Ohio
- I'm interested
North Coast Cancer Care
Sandusky, Ohio
- I'm interested
Cleveland Clinic Cancer Center Strongsville
Strongsville, Ohio
- I'm interested
University Hospitals Sharon Health Center
Wadsworth, Ohio
- I'm interested
South Pointe Hospital
Warrensville Heights, Ohio
- I'm interested
University of Cincinnati Cancer Center-West Chester
West Chester, Ohio
- I'm interested
UH Seidman Cancer Center at Saint John Medical Center
Westlake, Ohio
- I'm interested
UHHS-Westlake Medical Center
Westlake, Ohio
- I'm interested
Cleveland Clinic Wooster Family Health and Surgery Center
Wooster, Ohio
- I'm interested
Cleveland Clinic Cancer Center Mansfield
Mansfield, Ohio
- I'm interested
Cleveland Clinic Cancer Center Independence
Independence, Ohio
- I'm interested
Cleveland Clinic Akron General
Akron, Ohio
- I'm interested
Hillcrest Hospital Cancer Center
Mayfield Heights, Ohio
- I'm interested
Kaiser Permanente Northwest
Portland, Oregon
- I'm interested
Oregon Health and Science University
Portland, Oregon
- I'm interested
Penn State Milton S Hershey Medical Center
Hershey, Pennsylvania
- Call 800-836-0388
Guthrie Medical Group PC-Robert Packer Hospital
Sayre, Pennsylvania
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- I'm interested
Lehigh Valley Hospital - Muhlenberg
Bethlehem, Pennsylvania
- I'm interested
Lehigh Valley Hospital-Cedar Crest
Allentown, Pennsylvania
- Call 864-241-6251
Prisma Health Cancer Institute - Butternut
Greenville, South Carolina
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 864-241-6251
Prisma Health Cancer Institute - Faris
Greenville, South Carolina
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 864-241-6251
Prisma Health Cancer Institute - Eastside
Greenville, South Carolina
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- I'm interested
Baptist Memorial Hospital and Cancer Center-Memphis
Memphis, Tennessee
- I'm interested
UT Southwestern Clinical Center at Richardson/Plano
Richardson, Texas
- I'm interested
UT Southwestern/Simmons Cancer Center-Dallas
Dallas, Texas
- I'm interested
UT Southwestern/Simmons Cancer Center-Fort Worth
Fort Worth, Texas
- Call 540-332-5960
Augusta Health Center for Cancer and Blood Disorders
Fishersville, Virginia
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- I'm interested
Swedish Medical Center-First Hill
Seattle, Washington
- Call 800-804-8824
University of Washington Medical Center - Montlake
Seattle, Washington
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 360-788-8223
PeaceHealth Saint Joseph Medical Center
Bellingham, Washington
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- I'm interested
Swedish Cancer Institute-Issaquah
Issaquah, Washington
- Call 800-804-8824
FHCC South Lake Union
Seattle, Washington
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- I'm interested
West Virginia University Healthcare
Morgantown, West Virginia
- I'm interested
Camden Clark Medical Center
Parkersburg, West Virginia
- I'm interested
WVUH-Berkely Medical Center
Martinsburg, West Virginia
- Call 304-243-6442
Wheeling Hospital/Schiffler Cancer Center
Wheeling, West Virginia
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
Who can participate
Inclusion criteria
- ✓STEP 1 REGISTRATION
- ✓Patients must:
- ✓1. Have metastatic breast cancer, AND
- ✓2. Be initiating within 11 calendar days of Step 1 Registration OR be continuing trastuzumab-based HER-2 targeted therapy without concurrent anthracyclines, AND
- ✓3. Be receiving the trastuzumab-based HER-2 targeted therapy for metastatic disease in first, second, third-, or fourth-line setting. Patients may have brain metastasis. There is no limit for number of doses of HER-2 targeted therapy prior to registration.
- ✓Examples of eligible HER-2 targeted therapy:
- ✓Trastuzumab or a trastuzumab biosimilar
- ✓Trastuzumab + chemotherapy or hormonal therapy
- ✓Trastuzumab + other HER-2 targeted agent with or without chemotherapy (such as pertuzumab, lapatinib, and tucatinib)
- ✓Ado-trastuzumab (Kadcyla®)
- ✓Fam-trastuzumab deruxtecan (Enhertu) NOTE: Patients on lapatinib without trastuzumab are not eligible. Planned treatment with concurrent HER-2 targeted therapy and anthracyclines is not permitted.
- ✓Patients must be at increased risk for cardiotoxicity defined by at least one of the following:
- ✓1. Previous anthracycline exposure OR
- ✓2. 1 or more of the following risk factors for heart disease:
- ✓LVEF 50-54% by local ECHO read\*
- ✓Age ≥ 65
- ✓BMI ≥ 30 kg/m2
- ✓Current or prior anti-hypertensive therapy
- ✓Diagnosis of coronary artery disease (CAD)
- ✓Diagnosis of diabetes mellitus
- ✓Diagnosis of atrial fibrillation/flutter Note: ECHO can be performed at any time prior to registration with the most recent being sent.
- ✓Patients must not have taken within 21 days prior to Step 1 Registration, be currently taking at the time of Step 1 Registration or planning to take once registered to Step 1 a beta blocker, ARB, or ACE inhibitor, in order to be randomized (Arms 1 and 2).
- ✓Patients enrolling in the observational cohort (Arm 3) must be currently taking a beta blocker, ARB, or ACE inhibitor at the time of Step 1 Registration.
- ✓Patients must have a Zubrod Performance status of 0-2
- ✓Patients must have a complete physical examination and medical history within 28 days prior to registration
- ✓Patients must have LVEF \>= 50% echocardiogram (2D or 3D) within 28 days prior to registration. The echocardiogram must be obtained from a S1501 validated ECHO laboratory (lab) and submitted for central review by the S1501 ECHO core lab.
- ✓If a 3D echocardiogram is performed at baseline, sites must ensure that standard 2D images, including 40chamber and 2-chamber views, are also obtained and submitted at subsequent timepoints.
- ✓All follow-up echocardiograms (every 12 weeks) must be performed using 2D imaging to allow for standardized assessments. Follow-up scans must be completed at a site that can provide 2D images per protocol requirements. The echocardiograms cannot be submitted for central read until after Step 1 registration is complete.
- ✓Patients must have adequate hepatic function as evidenced by all of the following within 28 days prior to registration:
- ✓Serum bilirubin \< 3.0 x institutional upper limit of normal (IULN)
- ✓Serum glutamic oxaloacetic transaminase (SGOT)/aspartate aminotransferase (AST) and serum glutamic pyruvic transaminase (SGPT)/alanine aminotransferase (ALT) \< 5.0 x IULN
- ✓Patients must not be dialysis dependent
- ✓No other prior malignancy is allowed except for the following: adequately treated basal cell or squamous cell skin cancer, in situ cervical cancer, prostate cancer on active surveillance, adequately treated stage I or II cancer from which the patient is currently in complete remission, or any other cancer from which the patient has been disease free for five years
- ✓Patients must not be pregnant or nursing due to potential fetal or nursing infant harm; women/men of reproductive potential must have agreed to use an effective contraceptive method, a woman is considered to be of "reproductive potential" if she has had menses at any time in the preceding 12 consecutive months; in addition to routine contraceptive methods, "effective contraception" also includes heterosexual celibacy and surgery intended to prevent pregnancy (or with a side-effect of pregnancy prevention) defined as a hysterectomy, bilateral oophorectomy or bilateral tubal ligation; however, if at any point a previously celibate patient chooses to become heterosexually active during the time period for use of contraceptive measures outlined in the protocol, he/she is responsible for beginning contraceptive measures
- ✓Patients must be willing to submit blood specimens
- ✓Sites must seek additional patient consent for the future use of specimens
- ✓Patients must be informed of the investigational nature of this study and must sign and give written informed consent in accordance with institutional and federal guidelines
- ✓For participants with impaired decision-making capabilities, legally authorized representatives may sign and give informed consent on behalf of study participants in accordance with applicable federal, local, and CIRB regulations.
- ✓As a part of the OPEN registration process the treating institution's identity is provided in order to ensure that the current (within 365 days) date of institutional review board approval for this study has been entered in the system
- ✓STEP 2 REGISTRATION (Randomization)
- ✓Patients must not be registered to step 2 until confirming via RAVE EDC that the patient's LVEF by echocardiogram was \>= 50% by central review. Patients must be registered within 21 calendar days of submission of the ECHO study/
- ✓Site must verify that there is no known change in the step 1 eligibility since initial registration
Only the research team can confirm whether you qualify. The intake questionnaire is the best way to find out.
Completing a questionnaire on Clinably does not enroll you in a clinical trial or confirm your eligibility. Only the research team can determine whether you qualify to participate. These results are based on the information you provide and are intended to help you start a conversation with the research team.
Trial data sourced from ClinicalTrials.gov.